Models used for illustrative purposes only.  
 
Indications

BETASERON® (interferon beta-1b) is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.

Get your patients started on BETASERON and enroll them in BETAPLUS®

By enrolling in BETAPLUS, patients can take advantage of the full suite of
services BETASERON has to offer, including:

BETAPLUS is there 24/7, BETASERON

BETA Nurse Support

  • Injection training for new patients
  • 24/7 ongoing support
Electronic delivery, BETASERON

BETACONNECT

  • 1st and only electronic autoinjector for relapsing forms of MS
  • Available at no cost
The BETA Bridge program, BETASERON® (interferon beta-1b)

myBETAapp

  • Patients can track and automatically share their injection data
Zero dollar copay, BETASERON® (interferon beta-1b)

Financial Support

  • $0 copay, up to $14,500 in copay assistance each calendar year
  • For patients with insurance challenges, BETA Bridge can keep treatment going for up to 12 months at no cost. Patients with commercial insurance are eligible
When using the BETACONNECT autoinjector, injection data are automatically transferred to myBETAapp whenever the autoinjector is powered on and within range of a patient’s mobile device. myBETAapp must be open and running in order for data transfer to occur. Healthcare professionals must have BETACONNECT Navigator access, and a patient must enable sharing in myBETAapp for HCPs to obtain this information.

Contact a Bayer Sales Consultant

Please complete and submit the form below for a BETASERON rep to contact you for a meeting.


*Required fields.

First Name* is a required field
Last Name* is a required field
Address* is a required field
Address (Line 2) is a required field
City* is a required field
State* is a required field
ZIP Code* is a required field
Phone Number* is a required field
Email* is a required field
Confirm Email* is a required field
State License Number* is a required field

Please read our Privacy Policy for more information.


 
back to top arrow
Back to
Top